Beskrywing

Nanomaterials are at the leading edge of the rapidly developing field of nanotechnology with many potential applications in biology and medicine research. Nanomaterials offer great possibilities for biomedical applications because of their high flexibility, stability, modular character, and biocompatibility. The global nanoparticles in biology and medicine market in terms of revenue is set to grow by US$ 39 miljard tydens 2021-2027, groei teen 'n saamgestelde jaarlikse groeikoers (CAGR) van 7.4% gedurende die voorspellingsperiode, volgens die data- en ontledingsmaatskappy StrategyHelix.

Die verslag verskaf up-to-date markgrootte data vir tydperk 2017-2020 en voorspel tot 2027 covering key market aspects like sales value for nanoparticles in biology and medicine. The global nanoparticles in biology and medicine market is segmented on the basis of type, streek. Volgens tipe, it is categorized into biotechnology, drug development & formulation, and drug delivery systems. The drug delivery systems segment held the largest market share in 2020. Egter, the drug development & formulation segment is expected to witness the highest CAGR during the forecast period. By region, the nanoparticles in biology and medicine market is divided into North America, Asiatiese Stille-Oseaan, Europa, and Rest of the World (ROW). In 2020, the North America region held the largest share of the market, and the Asia Pacific region is anticipated to register the highest CAGR during 2021 aan 2027.

The report has profiled some of the key players of the market such as Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck KGaA, NanoCarrier Co. Bpk., Novartis AG.

Die verslag is 'n waardevolle hulpbron vir maatskappye en organisasies wat in hierdie bedryf aktief is. It provides a cohesive picture of the nanoparticles in biology and medicine market to help drive informed decision making for industry executives, beleidmakers, akademies, en ontleders.

Verslag Omvang

Tik: biotechnology, drug development & formulation, and drug delivery systems
Streek: Noord-Amerika, Asiatiese Stille-Oseaan, Europa, and Rest of the World (ROW)
Jare oorweeg: hierdie verslag dek die tydperk 2017 aan 2027

Sleutelvoordele vir belanghebbendes

Get a comprehensive picture of the global nanoparticles in biology and medicine market
Bepaal groeisektore en -neigings vir belegging
Understand what the future of the global nanoparticles in biology and medicine market looks like
Identifiseer die mededingende landskap en geleentheidsvenster

INHOUDSOPGAWE

1. Markdefinisie
2. Navorsingsmetodologie
3. Markdata & Outlook
3.1 Markwaarde
3.2 Markwaarde Voorspelling
4. Nanoparticles in Biology and Medicine Market by Type
4.1 Biotegnologie
4.2 Drug Development & Formulation
4.3 Drug Delivery Systems
5. Nanoparticles in Biology and Medicine Market by Region
5.1 Noord-Amerika
5.2 Asiatiese Stille-Oseaan
5.3 Europa
5.4 Rest Of The World (Row)
6. Maatskappy profiele
6.1 Bristol-Myers Squibb Company
6.2 F. Hoffmann-La Roche Ltd.
6.3 GlaxoSmithKline plc
6.4 Merck KGaA
6.5 NanoCarrier Co., Bpk.
6.6 Novartis AG
7. Bylaag
7.1 Oor StrategyHelix
7.2 Vrywaring